← Learning HubRESEARCH LIBRARYPublished studies and papers relevant to the peptides we carry. For educational and reference purposes only.RetatrutideRetatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetesRosenstock J, et al. — The Lancet (2023)10.1016/S0140-6736(23)01053-XTriple-hormone-receptor agonist retatrutide for obesityJastreboff AM, et al. — New England Journal of Medicine (2023)10.1056/NEJMoa2301972BPC-157Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tractSikiric P, et al. — Current Pharmaceutical Design (2018)10.2174/1381612824666180713104034BPC 157 and its role in accelerating wound healingCerovecki T, et al. — Journal of Physiology and Pharmacology (2010)TB-500Thymosin beta-4 promotes dermal healingPhilp D, et al. — Annals of the New York Academy of Sciences (2007)10.1196/annals.1389.018CJC-1295 DACProlonged stimulation of growth hormone secretion after a single dose of CJC-1295Teichman SL, et al. — Journal of Clinical Endocrinology & Metabolism (2006)10.1210/jc.2005-1905SemaxSemax, an analog of ACTH(4-10) with cognitive effectsAseev IV, et al. — Doklady Biological Sciences (2007)10.1134/S0012496607040126Neuroprotective effects of Semax in conditions of cerebral ischemiaGusev EI, et al. — Bulletin of Experimental Biology and Medicine (2005)10.1007/s10517-006-0031-1